Waltham, MA, September 21, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity EvidenceFirst™, a high-value subscription service that allows biopharmaceutical companies to take advantage of real-world insights like never before. EvidenceFirst allows organizations to benefit from big, robust data without dealing with the complexities, resource requirements, and costs associated with large data sets. With EvidenceFirst, biopharmaceutical companies can now utilize real-world insights on a broader range of projects with faster turnaround times.
The combination…
Read Now
Waltham, MA, September 16, 2020 – Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Rebecca McNamara as Chief Financial Officer (CFO) reporting directly to Dave Fitzhenry, Trinity’s CEO.
Ms. McNamara has a proven track record for leading growth strategies as well as complex operational initiatives and capital allocation strategies. She joins Trinity from Boston-based Cengage where she most recently served as the Chief Integration Officer. Ms. McNamara will lead Trinity’s already world-class Operations…
Read Now
Waltham, MA, September 9, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity CloudCast™, the revolutionary connected forecast modeling and management tool that fully leverages Microsoft® Excel®. CloudCast enables biopharma leaders to rapidly create, update, share, and compare scenarios of their demand forecasts with an easy-to-use web app and cloud-based security.
By leveraging Microsoft® Excel® or other commonly-used forecasting software, pharma forecasters can work with tools they know and trust, while generating an unlimited…
Read Now
Waltham, MA, July 27, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, published a new forecasting paper entitled Considerations for Forecasting the Spread of COVID-19: How can life sciences companies most accurately project the spread of COVID-19 to plan for the future? The paper details the steps that life sciences forecasters should take to ensure they are incorporating the right assumptions and data to most accurately project the spread of COVID-19.
The extraordinary worldwide effort to…
Read Now
Waltham, MA, July 22, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, published its newest TGaS report entitled, Commercial/Medical Partnership Landscape: Driving Improvements in Communications, Coordination and Effectiveness. The report finds that pharmaceutical companies that encourage a culture of ‘compliant collaboration’ between Commercial and Medical Affairs teams ensures strong alignment that is critical to a product’s success.
“Often times within pharma, the Commercial and Medical Affairs teams are truly a tale of two cultures – each…
Read Now
Waltham, MA, July 6, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, introduces the first weekly-updated, forecasting model for drugs and treatments impacted by COVID-19. Trinity COVIDCast is a flexible SEIR (susceptible, exposed, infectious, recovered) model that forecasts COVID-19 case counts and hospitalizations across the United States, EU5, China and Japan. COVIDCast is designed for forecasting or brand planning teams working on COVID-specific drugs, diagnostics and vaccines as well as for teams who are working to…
Read Now
Waltham, MA, June 24, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, announces the pharma industry’s first and only benchmarking-based launch planning offering. The Trinity Launch Planning Solution is deeply rooted in real drug launch experience to empower superior commercialization readiness.
Through proprietary technology, Trinity launch experts can quickly pull best practices from past effective launches of treatments in a specific therapeutic area based on unique benchmarking data. This allows Trinity to start with a solid…
Read Now
Waltham, MA, June 16, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, introduces a new turnkey stakeholder insight research tool that evaluates the impact of COVID-19 on patient management and load, prescribing and compliance behaviors and sales detailing relative to pre-COVID times. COVIDPulse helps pharma companies understand how the pandemic has impacted their base business, how telemedicine has changed the landscape and what change (if any) there has been on utilization of a specific product or…
Read Now
Waltham, MA, June 4,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, finds that New Product Planning
(NPP) pharmaceutical executives are uncertain about how COVID-19 will affect
the volume of business development efforts. According to the new brief entitled
Impact of COVID-19 on New Product Planning, NPP teams are mixed in their
expectations for the volume of business development (BD) efforts to change in
the near term due to the COVID-19 outbreak.
“NPP teams are seeking…
Read Now
Waltham, MA, May 27,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, found that the majority of in-depth
discussions at last week’s virtual TGaS Spring Summit focused on how pharmaceutical
companies’ commercial operations need to adjust in response to the current
pandemic. COVID-19-related topics that were addressed by the 337 pharmaceutical
executives included:
Implications of delayed clinical trialsNext steps for field force re-entry (state and
local guidelines, obtaining appropriate quantities of personal protective
equipment (PPE), planning…
Read Now
